APO Research
Talk to an analyst

APO RESEARCH · REPORT

Over the Counter (OTC) Analgesics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Over the Counter (OTC) Analgesics Industry Growth and Trends Forecast to 2032

31 December 2025103 pages

Choose your research edition.

Industry ResearchOver the Counter (OTC) Analgesics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Over the Counter (OTC) Analgesics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Over the Counter (OTC) Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over the Counter (OTC) Analgesics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Over the Counter (OTC) Analgesics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Over the Counter (OTC) Analgesics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Over the Counter (OTC) Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Over the Counter (OTC) Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Over the Counter (OTC) Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Over the Counter (OTC) Analgesics include Takeda Pharmaceutical Company Limited., Sanofi SA, Johnson & Johnson, Novartis, Pfizer, Bayer AG, AstraZeneca, Sun Pharma and Reckitt Benckiser Group PLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Over the Counter (OTC) Analgesics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Over the Counter (OTC) Analgesics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Over the Counter (OTC) Analgesics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Over the Counter (OTC) Analgesics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Over the Counter (OTC) Analgesics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Over the Counter (OTC) Analgesics Market by Company

Takeda Pharmaceutical Company Limited.

Sanofi SA

Johnson & Johnson

Novartis

Pfizer

Bayer AG

AstraZeneca

Sun Pharma

Reckitt Benckiser Group PLC

GlaxoSmithKline PLC

Boehringer Ingelheim International GmbH

Over the Counter (OTC) Analgesics Segment by Type

Tablet

Capsule

Other

Over the Counter (OTC) Analgesics Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Over the Counter (OTC) Analgesics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over the Counter (OTC) Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over the Counter (OTC) Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over the Counter (OTC) Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Over the Counter (OTC) Analgesics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Over the Counter (OTC) Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Capsule Table 3. Major Company of Other Table 4. Global Over the Counter (OTC) Analgesics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 6. Global Over the Counter (OTC) Analgesics Sales Market Share in Volume by Type (2021-2026) Table 7. Global Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (US$ Million) Table 8. Global Over the Counter (OTC) Analgesics Sales Market Share in Value by Type (2021-2026) Table 9. Global Over the Counter (OTC) Analgesics Price by Type (2021-2026) & (US$/Unit) Table 10. Global Over the Counter (OTC) Analgesics Sales by Type (2027-2032) & (K Units) Table 11. Global Over the Counter (OTC) Analgesics Sales Market Share in Volume by Type (2027-2032) Table 12. Global Over the Counter (OTC) Analgesics Sales by Type (2027-2032) & (US$ Million) Table 13. Global Over the Counter (OTC) Analgesics Sales Market Share in Value by Type (2027-2032) Table 14. Global Over the Counter (OTC) Analgesics Price by Type (2027-2032) & (US$/Unit) Table 15. North America Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 16. North America Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 18. Europe Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 22. Latin America Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (US$ Million) Table 25. Over the Counter (OTC) Analgesics Industry Trends Table 26. Over the Counter (OTC) Analgesics Industry Drivers Table 27. Over the Counter (OTC) Analgesics Industry Opportunities and Challenges Table 28. Over the Counter (OTC) Analgesics Industry Restraints Table 29. Global Over the Counter (OTC) Analgesics Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Over the Counter (OTC) Analgesics Revenue Market Share by Company (2021-2026) Table 31. Global Over the Counter (OTC) Analgesics Sales by Company (2021-2026) & (K Units) Table 32. Global Over the Counter (OTC) Analgesics Sales Share by Company (2021-2026) Table 33. Global Over the Counter (OTC) Analgesics Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Over the Counter (OTC) Analgesics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Over the Counter (OTC) Analgesics Major Company Production Sites and Headquarters Table 36. Global Over the Counter (OTC) Analgesics Company, Product Type & Application Table 37. Global Over the Counter (OTC) Analgesics Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Over the Counter (OTC) Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Over the Counter (OTC) Analgesics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Over the Counter (OTC) Analgesics Sales by Region (2021-2026) & (K Units) Table 42. Global Over the Counter (OTC) Analgesics Sales Market Share in Volume by Region (2021-2026) Table 43. Global Over the Counter (OTC) Analgesics Sales by Region (2021-2026) & (US$ Million) Table 44. Global Over the Counter (OTC) Analgesics Sales Market Share in Value by Region (2021-2026) Table 45. Global Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Over the Counter (OTC) Analgesics Sales by Region (2027-2032) & (K Units) Table 47. Global Over the Counter (OTC) Analgesics Sales Market Share in Volume by Region (2027-2032) Table 48. Global Over the Counter (OTC) Analgesics Sales by Region (2027-2032) & (US$ Million) Table 49. Global Over the Counter (OTC) Analgesics Sales Market Share in Value by Region (2027-2032) Table 50. Global Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Over the Counter (OTC) Analgesics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 53. Global Over the Counter (OTC) Analgesics Sales Market Share in Volume by Application (2021-2026) Table 54. Global Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (US$ Million) Table 55. Global Over the Counter (OTC) Analgesics Sales Market Share in Value by Application (2021-2026) Table 56. Global Over the Counter (OTC) Analgesics Price by Application (2021-2026) & (US$/Unit) Table 57. Global Over the Counter (OTC) Analgesics Sales by Application (2027-2032) & (K Units) Table 58. Global Over the Counter (OTC) Analgesics Sales Market Share in Volume by Application (2027-2032) Table 59. Global Over the Counter (OTC) Analgesics Sales by Application (2027-2032) & (US$ Million) Table 60. Global Over the Counter (OTC) Analgesics Sales Market Share in Value by Application (2027-2032) Table 61. Global Over the Counter (OTC) Analgesics Price by Application (2027-2032) & (US$/Unit) Table 62. North America Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 63. North America Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 65. Europe Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 69. Latin America Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (US$ Million) Table 72. Takeda Pharmaceutical Company Limited. Company Information Table 73. Takeda Pharmaceutical Company Limited. Business Overview Table 74. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product Portfolio Table 76. Takeda Pharmaceutical Company Limited. Recent Development Table 77. Sanofi SA Company Information Table 78. Sanofi SA Business Overview Table 79. Sanofi SA Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sanofi SA Over the Counter (OTC) Analgesics Product Portfolio Table 81. Sanofi SA Recent Development Table 82. Johnson & Johnson Company Information Table 83. Johnson & Johnson Business Overview Table 84. Johnson & Johnson Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Johnson & Johnson Over the Counter (OTC) Analgesics Product Portfolio Table 86. Johnson & Johnson Recent Development Table 87. Novartis Company Information Table 88. Novartis Business Overview Table 89. Novartis Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Novartis Over the Counter (OTC) Analgesics Product Portfolio Table 91. Novartis Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Pfizer Over the Counter (OTC) Analgesics Product Portfolio Table 96. Pfizer Recent Development Table 97. Bayer AG Company Information Table 98. Bayer AG Business Overview Table 99. Bayer AG Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bayer AG Over the Counter (OTC) Analgesics Product Portfolio Table 101. Bayer AG Recent Development Table 102. AstraZeneca Company Information Table 103. AstraZeneca Business Overview Table 104. AstraZeneca Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. AstraZeneca Over the Counter (OTC) Analgesics Product Portfolio Table 106. AstraZeneca Recent Development Table 107. Sun Pharma Company Information Table 108. Sun Pharma Business Overview Table 109. Sun Pharma Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sun Pharma Over the Counter (OTC) Analgesics Product Portfolio Table 111. Sun Pharma Recent Development Table 112. Reckitt Benckiser Group PLC Company Information Table 113. Reckitt Benckiser Group PLC Business Overview Table 114. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product Portfolio Table 116. Reckitt Benckiser Group PLC Recent Development Table 117. GlaxoSmithKline PLC Company Information Table 118. GlaxoSmithKline PLC Business Overview Table 119. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product Portfolio Table 121. GlaxoSmithKline PLC Recent Development Table 122. Boehringer Ingelheim International GmbH Company Information Table 123. Boehringer Ingelheim International GmbH Business Overview Table 124. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product Portfolio Table 126. Boehringer Ingelheim International GmbH Recent Development Table 127. North America Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 129. North America Over the Counter (OTC) Analgesics Sales Market Share by Country (2021-2026) Table 130. North America Over the Counter (OTC) Analgesics Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Over the Counter (OTC) Analgesics Sales Market Share Forecast by Country (2027-2032) Table 132. North America Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Over the Counter (OTC) Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Over the Counter (OTC) Analgesics Market Share by Country (2021-2026) Table 135. North America Over the Counter (OTC) Analgesics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Over the Counter (OTC) Analgesics Market Share Forecast by Country (2027-2032) Table 137. Europe Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 139. Europe Over the Counter (OTC) Analgesics Sales Market Share by Country (2021-2026) Table 140. Europe Over the Counter (OTC) Analgesics Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Over the Counter (OTC) Analgesics Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Over the Counter (OTC) Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Over the Counter (OTC) Analgesics Market Share by Country (2021-2026) Table 145. Europe Over the Counter (OTC) Analgesics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Over the Counter (OTC) Analgesics Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Over the Counter (OTC) Analgesics Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Over the Counter (OTC) Analgesics Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Over the Counter (OTC) Analgesics Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Over the Counter (OTC) Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Over the Counter (OTC) Analgesics Market Share by Country (2021-2026) Table 155. Asia-Pacific Over the Counter (OTC) Analgesics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Over the Counter (OTC) Analgesics Market Share Forecast by Country (2027-2032) Table 157. Latin America Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 159. Latin America Over the Counter (OTC) Analgesics Sales Market Share by Country (2021-2026) Table 160. Latin America Over the Counter (OTC) Analgesics Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Over the Counter (OTC) Analgesics Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Over the Counter (OTC) Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Over the Counter (OTC) Analgesics Market Share by Country (2021-2026) Table 165. Latin America Over the Counter (OTC) Analgesics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Over the Counter (OTC) Analgesics Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Over the Counter (OTC) Analgesics Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Over the Counter (OTC) Analgesics Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Over the Counter (OTC) Analgesics Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Over the Counter (OTC) Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Over the Counter (OTC) Analgesics Market Share by Country (2021-2026) Table 175. Middle East and Africa Over the Counter (OTC) Analgesics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Over the Counter (OTC) Analgesics Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Over the Counter (OTC) Analgesics Distributors List Table 180. Over the Counter (OTC) Analgesics Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Over the Counter (OTC) Analgesics Image Figure 2. Global Over the Counter (OTC) Analgesics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Over the Counter (OTC) Analgesics Market Size (2021-2032) & (US$ Million) Figure 4. Global Over the Counter (OTC) Analgesics Sales (2021-2032) & (K Units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsule Image Figure 8. Global Capsule Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Over the Counter (OTC) Analgesics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Over the Counter (OTC) Analgesics Market Share by Type 2025 VS 2032 Figure 13. North America Over the Counter (OTC) Analgesics Sales Market Share in Volume by Type in 2025 Figure 14. North America Over the Counter (OTC) Analgesics Sales Market Share in Value by Type in 2025 Figure 15. Europe Over the Counter (OTC) Analgesics Sales Market Share in Volume by Type in 2025 Figure 16. Europe Over the Counter (OTC) Analgesics Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Over the Counter (OTC) Analgesics Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Over the Counter (OTC) Analgesics Sales Market Share in Value by Type in 2025 Figure 19. Latin America Over the Counter (OTC) Analgesics Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Over the Counter (OTC) Analgesics Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Over the Counter (OTC) Analgesics Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Over the Counter (OTC) Analgesics Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Over the Counter (OTC) Analgesics Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Online Pharmacies Image Figure 28. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Over the Counter (OTC) Analgesics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Over the Counter (OTC) Analgesics Market Share by Application 2025 VS 2032 Figure 33. North America Over the Counter (OTC) Analgesics Sales Market Share in Volume by Application in 2025 Figure 34. North America Over the Counter (OTC) Analgesics Sales Market Share in Value by Application in 2025 Figure 35. Europe Over the Counter (OTC) Analgesics Sales Market Share in Volume by Application in 2025 Figure 36. Europe Over the Counter (OTC) Analgesics Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Over the Counter (OTC) Analgesics Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Over the Counter (OTC) Analgesics Sales Market Share in Value by Application in 2025 Figure 39. Latin America Over the Counter (OTC) Analgesics Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Over the Counter (OTC) Analgesics Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Over the Counter (OTC) Analgesics Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Over the Counter (OTC) Analgesics Sales Market Share in Value by Application in 2025 Figure 43. North America Over the Counter (OTC) Analgesics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Over the Counter (OTC) Analgesics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Over the Counter (OTC) Analgesics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Over the Counter (OTC) Analgesics Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Over the Counter (OTC) Analgesics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Over the Counter (OTC) Analgesics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Over the Counter (OTC) Analgesics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Over the Counter (OTC) Analgesics Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Over the Counter (OTC) Analgesics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Over the Counter (OTC) Analgesics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Over the Counter (OTC) Analgesics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Over the Counter (OTC) Analgesics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Over the Counter (OTC) Analgesics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Over the Counter (OTC) Analgesics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Over the Counter (OTC) Analgesics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Over the Counter (OTC) Analgesics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Over the Counter (OTC) Analgesics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Over the Counter (OTC) Analgesics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Over the Counter (OTC) Analgesics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Over the Counter (OTC) Analgesics Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Over the Counter (OTC) Analgesics Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Over the Counter (OTC) Analgesics Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Other
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Takeda Pharmaceutical Company Limited.
  • Sanofi SA
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Bayer AG
  • AstraZeneca
  • Sun Pharma
  • Reckitt Benckiser Group PLC
  • GlaxoSmithKline PLC
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Over the Counter (OTC) Analgesics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Over the Counter (OTC) Analgesics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Over the Counter (OTC) Analgesics Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Capsule
  8. 1.3.3 Other
  9. 1.4 Global Over the Counter (OTC) Analgesics Market Size by Type
  10. 1.4.1 Global Over the Counter (OTC) Analgesics Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Over the Counter (OTC) Analgesics Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Over the Counter (OTC) Analgesics Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Over the Counter (OTC) Analgesics Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Over the Counter (OTC) Analgesics Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Over the Counter (OTC) Analgesics Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Over the Counter (OTC) Analgesics Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Over the Counter (OTC) Analgesics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Over the Counter (OTC) Analgesics Industry Trends
  2. 2.2 Over the Counter (OTC) Analgesics Industry Drivers
  3. 2.3 Over the Counter (OTC) Analgesics Industry Opportunities and Challenges
  4. 2.4 Over the Counter (OTC) Analgesics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Over the Counter (OTC) Analgesics Revenue (2021-2026)
  2. 3.2 Global Top Players by Over the Counter (OTC) Analgesics Sales (2021-2026)
  3. 3.3 Global Top Players by Over the Counter (OTC) Analgesics Price (2021-2026)
  4. 3.4 Global Over the Counter (OTC) Analgesics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Over the Counter (OTC) Analgesics Major Company Production Sites & Headquarters
  6. 3.6 Global Over the Counter (OTC) Analgesics Company, Product Type & Application
  7. 3.7 Global Over the Counter (OTC) Analgesics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Over the Counter (OTC) Analgesics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Over the Counter (OTC) Analgesics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Over the Counter (OTC) Analgesics Tier 1, Tier 2, and Tier 3
4 Over the Counter (OTC) Analgesics Regional Status and Outlook
  1. 4.1 Global Over the Counter (OTC) Analgesics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Over the Counter (OTC) Analgesics Historic Market Size by Region
  3. 4.2.1 Global Over the Counter (OTC) Analgesics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Over the Counter (OTC) Analgesics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Over the Counter (OTC) Analgesics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Over the Counter (OTC) Analgesics Forecasted Market Size by Region
  7. 4.3.1 Global Over the Counter (OTC) Analgesics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Over the Counter (OTC) Analgesics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Over the Counter (OTC) Analgesics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Over the Counter (OTC) Analgesics by Application
  1. 5.1 Over the Counter (OTC) Analgesics Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Over the Counter (OTC) Analgesics Market Size by Application
  6. 5.2.1 Global Over the Counter (OTC) Analgesics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Over the Counter (OTC) Analgesics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Over the Counter (OTC) Analgesics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Over the Counter (OTC) Analgesics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Over the Counter (OTC) Analgesics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Over the Counter (OTC) Analgesics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Over the Counter (OTC) Analgesics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Over the Counter (OTC) Analgesics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Company Limited.
  2. 6.1.1 Takeda Pharmaceutical Company Limited. Company Information
  3. 6.1.2 Takeda Pharmaceutical Company Limited. Business Overview
  4. 6.1.3 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Company Limited. Recent Developments
  7. 6.2 Sanofi SA
  8. 6.2.1 Sanofi SA Company Information
  9. 6.2.2 Sanofi SA Business Overview
  10. 6.2.3 Sanofi SA Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi SA Over the Counter (OTC) Analgesics Product Portfolio
  12. 6.2.5 Sanofi SA Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Over the Counter (OTC) Analgesics Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Over the Counter (OTC) Analgesics Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Over the Counter (OTC) Analgesics Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Bayer AG
  32. 6.6.1 Bayer AG Company Information
  33. 6.6.2 Bayer AG Business Overview
  34. 6.6.3 Bayer AG Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer AG Over the Counter (OTC) Analgesics Product Portfolio
  36. 6.6.5 Bayer AG Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Over the Counter (OTC) Analgesics Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Sun Pharma
  44. 6.8.1 Sun Pharma Company Information
  45. 6.8.2 Sun Pharma Business Overview
  46. 6.8.3 Sun Pharma Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharma Over the Counter (OTC) Analgesics Product Portfolio
  48. 6.8.5 Sun Pharma Recent Developments
  49. 6.9 Reckitt Benckiser Group PLC
  50. 6.9.1 Reckitt Benckiser Group PLC Company Information
  51. 6.9.2 Reckitt Benckiser Group PLC Business Overview
  52. 6.9.3 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product Portfolio
  54. 6.9.5 Reckitt Benckiser Group PLC Recent Developments
  55. 6.10 GlaxoSmithKline PLC
  56. 6.10.1 GlaxoSmithKline PLC Company Information
  57. 6.10.2 GlaxoSmithKline PLC Business Overview
  58. 6.10.3 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product Portfolio
  60. 6.10.5 GlaxoSmithKline PLC Recent Developments
  61. 6.11 Boehringer Ingelheim International GmbH
  62. 6.11.1 Boehringer Ingelheim International GmbH Company Information
  63. 6.11.2 Boehringer Ingelheim International GmbH Business Overview
  64. 6.11.3 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product Portfolio
  66. 6.11.5 Boehringer Ingelheim International GmbH Recent Developments
7 North America by Country
  1. 7.1 North America Over the Counter (OTC) Analgesics Sales by Country
  2. 7.1.1 North America Over the Counter (OTC) Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Over the Counter (OTC) Analgesics Sales by Country (2021-2026)
  4. 7.1.3 North America Over the Counter (OTC) Analgesics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Over the Counter (OTC) Analgesics Market Size by Country
  6. 7.2.1 North America Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Over the Counter (OTC) Analgesics Market Size by Country (2021-2026)
  8. 7.2.3 North America Over the Counter (OTC) Analgesics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Over the Counter (OTC) Analgesics Sales by Country
  2. 8.1.1 Europe Over the Counter (OTC) Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Over the Counter (OTC) Analgesics Sales by Country (2021-2026)
  4. 8.1.3 Europe Over the Counter (OTC) Analgesics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Over the Counter (OTC) Analgesics Market Size by Country
  6. 8.2.1 Europe Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Over the Counter (OTC) Analgesics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Over the Counter (OTC) Analgesics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Over the Counter (OTC) Analgesics Sales by Country
  2. 9.1.1 Asia-Pacific Over the Counter (OTC) Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Over the Counter (OTC) Analgesics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Over the Counter (OTC) Analgesics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Over the Counter (OTC) Analgesics Market Size by Country
  6. 9.2.1 Asia-Pacific Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Over the Counter (OTC) Analgesics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Over the Counter (OTC) Analgesics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Over the Counter (OTC) Analgesics Sales by Country
  2. 10.1.1 South America Over the Counter (OTC) Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Over the Counter (OTC) Analgesics Sales by Country (2021-2026)
  4. 10.1.3 South America Over the Counter (OTC) Analgesics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Over the Counter (OTC) Analgesics Market Size by Country
  6. 10.2.1 South America Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Over the Counter (OTC) Analgesics Market Size by Country (2021-2026)
  8. 10.2.3 South America Over the Counter (OTC) Analgesics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Over the Counter (OTC) Analgesics Sales by Country
  2. 11.1.1 Middle East and Africa Over the Counter (OTC) Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Over the Counter (OTC) Analgesics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Over the Counter (OTC) Analgesics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Over the Counter (OTC) Analgesics Market Size by Country
  6. 11.2.1 Middle East and Africa Over the Counter (OTC) Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Over the Counter (OTC) Analgesics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Over the Counter (OTC) Analgesics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Over the Counter (OTC) Analgesics Value Chain Analysis
  2. 12.1.1 Over the Counter (OTC) Analgesics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Over the Counter (OTC) Analgesics Production Mode & Process
  7. 12.2 Over the Counter (OTC) Analgesics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Over the Counter (OTC) Analgesics Distributors
  10. 12.2.3 Over the Counter (OTC) Analgesics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst